| Cost effectiveness of hepatocellular carcinoma surveillance after a sustained virologic response to therapy in patients with hepatitis C virus infection and advanced fibrosis HF Zangneh, WWL Wong, B Sander, CM Bell, K Mumtaz, M Kowgier, ... Clinical Gastroenterology and Hepatology 17 (9), 1840-1849. e16, 2019 | 105 | 2019 |
| Cost-effectiveness of screening for hepatitis C in Canada WWL Wong, HA Tu, JJ Feld, T Wong, M Krahn Cmaj 187 (3), E110-E121, 2015 | 89 | 2015 |
| Examining trends in cost and clinical benefit of novel anticancer drugs over time R Saluja, VS Arciero, S Cheng, E McDonald, WWL Wong, MC Cheung, ... Journal of oncology practice 14 (5), e280-e294, 2018 | 88 | 2018 |
| Cost effectiveness of screening immigrants for hepatitis B WWL Wong, G Woo, E Jenny Heathcote, M Krahn Liver International 31 (8), 1179-1190, 2011 | 63 | 2011 |
| Lenvatinib Versus Sorafenib as First‐Line Treatment of Unresectable Hepatocellular Carcinoma: A Cost–Utility Analysis JJ Kim, T McFarlane, S Tully, WWL Wong The oncologist 25 (3), e512-e519, 2020 | 60 | 2020 |
| HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies M van Tilborg, SH Al Marzooqi, WWL Wong, R Maan, J Vermehren, ... The Lancet Gastroenterology & Hepatology 3 (12), 856-864, 2018 | 60 | 2018 |
| A constructive approach for discovering new drug leads: Using a kernel methodology for the inverse-QSAR problem WWL Wong, FJ Burkowski Journal of cheminformatics 1, 1-27, 2009 | 58 | 2009 |
| Impact of wait times on the effectiveness of transcatheter aortic valve replacement in severe aortic valve disease: a discrete event simulation model HC Wijeysundera, WWL Wong, MC Bennell, SE Fremes, ... Canadian Journal of Cardiology 30 (10), 1162-1169, 2014 | 51 | 2014 |
| Disease burden of chronic hepatitis B among immigrants in Canada WWL Wong, G Woo, EJ Heathcote, M Krahn Canadian Journal of Gastroenterology and Hepatology 27, 137-147, 2013 | 43 | 2013 |
| Population-based estimate of hepatitis C virus prevalence in Ontario, Canada S Bolotin, JJ Feld, G Garber, WWL Wong, FM Guerra, T Mazzulli PLoS One 13 (1), e0191184, 2018 | 41 | 2018 |
| Estimation of fibrosis progression rates for chronic hepatitis C: a systematic review and meta-analysis update A Erman, MD Krahn, T Hansen, J Wong, JM Bielecki, JJ Feld, WWL Wong, ... BMJ open 9 (11), e027491, 2019 | 38 | 2019 |
| Cost‐effectiveness of nivolumab in recurrent metastatic head and neck squamous cell carcinoma M Zargar, T McFarlane, KKW Chan, WWL Wong The Oncologist 23 (2), 225-233, 2018 | 35 | 2018 |
| Generalized genetic association study with samples of related individuals Z Feng, WWL Wong, X Gao, F Schenkel | 35 | 2011 |
| Antiviral treatment for treatment-naïve chronic hepatitis B: systematic review and network meta-analysis of randomized controlled trials WWL Wong, P Pechivanoglou, J Wong, JM Bielecki, A Haines, A Erman, ... Systematic Reviews 8, 1-15, 2019 | 33 | 2019 |
| A systematic review and meta-analysis of health utilities in patients with chronic hepatitis C YA Saeed, A Phoon, JM Bielecki, N Mitsakakis, KE Bremner, ... Value in Health 23 (1), 127-137, 2020 | 32 | 2020 |
| Impact of increasing wait times on overall mortality of chimeric antigen receptor T-cell therapy in large B-cell lymphoma: a discrete event simulation model S Tully, Z Feng, K Grindrod, T McFarlane, KKW Chan, WWL Wong JCO Clinical Cancer Informatics 3, 1-9, 2019 | 32 | 2019 |
| Model-based projection of health and economic effects of screening for hepatitis C in Canada WWL Wong, A Erman, JJ Feld, M Krahn Canadian Medical Association Open Access Journal 5 (3), E662-E672, 2017 | 32 | 2017 |
| Drug therapies for chronic hepatitis C infection: a cost-effectiveness analysis WWL Wong, KM Lee, S Singh, G Wells, JJ Feld, M Krahn Canadian Medical Association Open Access Journal 5 (1), E97-E108, 2017 | 31 | 2017 |
| Cost-Effectiveness Analysis of Different Sequences of the Use of Epidermal Growth Factor Receptor Inhibitors for Wild-Type KRAS Unresectable Metastatic … MC Riesco-Martínez, SR Berry, YJ Ko, N Mittmann, A Giotis, K Lien, ... Journal of oncology practice 12 (6), e710-e723, 2016 | 27 | 2016 |
| Cost effectiveness of in vitro fertilisation and preimplantation genetic testing to prevent transmission of BRCA1/2 mutations JH Lipton, M Zargar, E Warner, EE Greenblatt, E Lee, KKW Chan, ... Human Reproduction 35 (2), 434-445, 2020 | 24 | 2020 |
